Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Other Non Operating Income: 2015-2024

Historic Other Non Operating Income for Insight Molecular Diagnostics (IMDX) over the last 9 years, with Dec 2024 value amounting to $462,000.

  • Insight Molecular Diagnostics' Other Non Operating Income rose 320.75% to $223,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $651,000, marking a year-over-year increase of 11.28%. This contributed to the annual value of $462,000 for FY2024, which is 17.26% up from last year.
  • According to the latest figures from FY2024, Insight Molecular Diagnostics' Other Non Operating Income is $462,000, which was up 17.26% from $394,000 recorded in FY2023.
  • Insight Molecular Diagnostics' 5-year Other Non Operating Income high stood at $1.1 million for FY2021, and its period low was -$67,000 during FY2022.
  • Moreover, its 3-year median value for Other Non Operating Income was $394,000 (2023), whereas its average is $263,000.
  • As far as peak fluctuations go, Insight Molecular Diagnostics' Other Non Operating Income spiked by 4,125.93% in 2021, and later slumped by 105.87% in 2022.
  • Insight Molecular Diagnostics' Other Non Operating Income (Yearly) stood at $27,000 in 2020, then surged by 4,125.93% to $1.1 million in 2021, then tumbled by 105.87% to -$67,000 in 2022, then surged by 688.06% to $394,000 in 2023, then grew by 17.26% to $462,000 in 2024.